Номер части:
|
|||||||||||||
Журнал
|
ISSN: 2411-6467 (Print)
ISSN: 2413-9335 (Online)
Статьи, опубликованные в журнале, представляется читателям на условиях свободной лицензии CC BY-ND
ISSN: 2413-9335 (Online)
Статьи, опубликованные в журнале, представляется читателям на условиях свободной лицензии CC BY-ND
THE INFLUENCE OF CONCOMITANT IMMUNE PHARMACOTHERAPY ON ANTIOXIDANT DEFENSE SYSTEM IN PATIENTS WITH CERVICAL CANCER (44-48)
Науки и перечень статей вошедших в журнал:
DOI:
Дата публикации статьи в журнале: 2018/04/16
Название журнала: Евразийский Союз Ученых — публикация научных статей в ежемесячном научном журнале, Выпуск:
48, Том: 1,
Страницы в выпуске: 44-48
Автор:
Kamishov S.V.
, Republican Specilized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan, Tashkent
, Republican Specilized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan, Tashkent
Автор:
Pulatov D.A.
, Republican Specilized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan, Tashkent
, Republican Specilized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan, Tashkent
Автор:
Enikeeva Z.M.
, Republican Specilized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan, Tashkent
, Republican Specilized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan, Tashkent
Анотация: The level of H2O2-induced chemiluminescence (CHL), product lipoperoxidation (LP) and the state of enzymatic antioxidant protection (AP) of the system was studied in 95 patients with cervical cancer stage II-III, who received accompanying extracorporeal immunopharmacotherapy (EIPT). The content of LP products in patients' erythrocytes and the activity of glutathione-dependent enzymes were initially high. After EIPT, the intensity of these processes was significantly reduced. Immunotherapy increased the activity of catalase and superoxide dismutase. In СС(cervical cancer) patients, the underlying disease and chemoradiotherapy can increase the content of hydroxide in the body, causing an imbalance in the LP/AP system. EIPT as a concomitant therapy can significantly reduce this imbalance.
Ключевые слова:
glutathione-s-peroxidase (HSP),
glutathione-s-reductase (GR),glutathione-s-transferase (GST),catalase,chemoluminescence,lipid peroxidation (LP),plasmapheresis (PP),cervical cancer (СС),extracorporeal immunopharmacotherapy (EIPT),
Данные для цитирования: Kamishov S.V. Pulatov D.A. Enikeeva Z.M.. THE INFLUENCE OF CONCOMITANT IMMUNE PHARMACOTHERAPY ON ANTIOXIDANT DEFENSE SYSTEM IN PATIENTS WITH CERVICAL CANCER (44-48) // Евразийский Союз Ученых — публикация научных статей в ежемесячном научном журнале.
Медицинские науки.
2018/04/16;
48(1):44-48.
Список литературы: 1. Arslanova D.R., Antoneyeva I.I., Abakumova T.V., Sidorenko E.G., Voronova O.S. (2011) Antioxidant protection enzymes in tumor tissue with cervical cancer]. Siberian OncoJ, 1:13.
2. Barsukov V., Chesnokova N. (2008) Activation of lipid peroxidation and failure of antioxidative system in the development of structural and functional disorganization of breast tissue in the area of neoplasia. Russian J Onco, 3:31-32.
3. GoroshinskayaI., Kachesova P., Nerodo G., Kalabanova E., Shalashnaya E., Surikova E., Nemashkalova L., Neskubina I. (2011) A comparative study of oxidation of proteins and lipids in the blood plasma of patients with cervical cancer with and without metastases. Palliative medicine and rehabilitation, 1: 45-49 (in Russian).
4. Gushchin I.S. Experimental validation of extracorporeal immunopharmacotherapy. In: Gushchin I.S., Leskov V.P., Prozorovskij N.S., Pisarev V.M. Topical of issues immunopharmacotherapy.– Мoscow: Medicine, 1987. pp. 71-76 (in Russian).
5. Kamishov S.V., Pulatov D.A. Supportive immunotherapy in complex treatment of patients with oncogynecologycal diseases.// The Scientific Heritage (Budapest, Hungary) 18 (18) 2017 Р.1, p. 23-27.
6. Maneo A., Colombo A., Landoni F. (2005) Treatment of stage IIIB cervical carcinoma. A comparison between radiotherapy, concurrent chemo-radiotherapy and neoadjuvant chemotherapy. Minerva Ginecology, 57 (2): 141-152.
7. Manju V., Kalaivani J. Sailaja, Nalini N. (2002) Circulating lipid peroxidation and antioxidative status in cervical cancer patients: a case-control study. Clin Biochem, 35(8): 621-625.
8. Manoharan S., Klanjiappan K., Kayalvizi M. (2004) Enhanced Lipid peroxidation and impaired enzymatic antioxidative activities in the erythrocytes of the patients with cervical carcinoma. Cell Mol Bio Lett,9, (4A): 699-707.
9. Ray G., Husain S.A. (2002) Oxidants, antioxidatives and carcinogenesis Indian. J Exp Biol, 40(11): 1213-1232.
10. Rosenberg S., Restifo N., Yang J., Morgan R., Dudley M. (2008) Adoptive cell transfer a clinical path to effective cancer immunotherapy. Nature
Reviews Cancer, 8:299-308.